Triple-negative breast cancer (TNBC), defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, represents a particularly aggressive and heterogeneous subtype. This evidence concerns the gene PGR and triple-negative breast carcinoma.